Fibromyalgia is a common health condition marked by widespread sensitivity and pain in the muscle and joints. For many people diagnosed with fibromyalgia, the pain and tenderness is constant, but the severity changes from time to time. The symptoms of fibromyalgia were first described in the early 1800s when the condition was called “muscular rheumatism,” but fibromyalgia is still...
Post
What to eat and what to avoid with gout
Gout is a type of arthritis that causes severe pain, tenderness, redness, and inflammation. It often affects the feet. Medications can help relieve symptoms and reduce uric acid levels, but dietary changes can also help prevent further attacks. Diet and gout Studies have shown that consuming certain types of food can bring on a gout attack. Substances known...
Post
Diabetes patch ends the pain of finger-prick tests: Sensor inside reads blood sugar levels from cells before transmitting data to a smartphone
Sensor the size of a £2 coin measures sugar levels from cells just below the skin £96-a-month Freestyle Libre is available privately and use by 20,000 diabetics Manufacturer Abbott is in negotiations to make it available on the NHS for free An arm patch could change the lives of tens of thousands of diabetes patients...
Post
DARPA: We’re Moving to Merge Humans and Machines
IN BRIEF The U.S. Department of Defense is researching several ways to enhance humans using technology, from strength-enhancing exoskeletons to quick-processing brain implants. With AI already proving more adept than humans at a number of tasks, merging biological and machine intelligence might be humanity’s only hope of keeping up. IF YOU CAN’T BEAT THEM… Without...
Post
Disease gougers: New Big Pharma scandal as FDA approves drug for terminal muscular dystrophy – but manufacturer hikes the price from $1,000 to $89,000 a year
Emflaza, a steroid, is one of the only drugs known to slow the effects of DMD Duchenne’s muscular dystrophy is a terminal disease that mainly affects boys Previously, families could import the drug to the US for around $1,000 a year Last week it was approved by the FDA for US use – but the...
Post
Four-in-one 'miracle' pill to cure high blood pressure: Every patient given treatment during trial saw their hypertension drop to healthy levels
Those given the four-in-one ‘quadpill’ saw blood pressure drop in a month Experts believe the combined medication will minimise side-effects High blood pressure affects more than 17million Britons, or one adult in three Combining four blood pressure drugs into a single pill could be twice as effective as existing treatments, researchers have found. In a...
Post
The glaucoma operation that saves you from going BLIND: New technique releases pressure on the eye, and saves you from needing constant eye drops
Millions of people have glaucoma, which could cause blindness if left untreated Last month Asteroulla Antoniou, 76, became one of the first to try the procedure Half a million Britons have glaucoma, which can cause blindness if left untreated. Last month, Asteroulla Antoniou, 76, a retired dressmaker from London, underwent a new operation to treat...
Post
Gilead HIV drug aces phase 2, teeing up tussle with GSK
Gilead is looking to bictegravir to defend its HIV franchise against GSK Gilead has posted upbeat phase 2 data on its next-generation integrase inhibitor bictegravir in HIV patients. The drug more than held its own against GlaxoSmithKline’s dolutegravir, setting the stage for a larger-scale comparison in phase 3 and potential scrap for a multibillion-dollar market. The trial...
Post
Scientists Reveal How the Brain Maintains Useful Memories
Researchers from the University of Toronto, Canada, have discovered a reason why we often struggle to remember the smaller details of past experiences. Writing in the journal eLife, the team found that there are specific groups of neurons in the medial prefrontal cortex (mPFC) of a rat’s brain – the region most associated with long-term memory....
Post
Mitochondrial lipids as potential targets in early onset Parkinson's disease
A team of researchers led by Patrik Verstreken (VIB-KU Leuven) have identified an underlying mechanism in early onset Parkinson’s. Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells’ mitochondria, organelles that produce energy. They demonstrated that reducing the effects of the protein FASN influences the mitochondria, leading to...